• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年临床医生需要了解的大麻过敏知识。

Cannabis allergy: what the clinician needs to know in 2019.

机构信息

a Department of Immunology-Allergology-Rheumatology , Antwerp University Hospital, University of Antwerp , Antwerp , Belgium.

b Department of Pediatrics , Antwerp University Hospital, University of Antwerp , Antwerp , Belgium.

出版信息

Expert Rev Clin Immunol. 2019 Jun;15(6):599-606. doi: 10.1080/1744666X.2019.1600403. Epub 2019 Apr 4.

DOI:10.1080/1744666X.2019.1600403
PMID:30946607
Abstract

Although the use of cannabis dates back millennia, the first description of cannabis allergy is relatively recent (1971). Recent large-scale data show that cannabis allergy can manifest severe and generalized symptoms with extensive cross-reactions. Thus, it is essential to become familiarized with its clinical presentation, diagnostic aids, and adequate therapeutic guidance. Areas covered: Here we provide a hands-on overview on cannabis allergy focusing on symptomatology and the reliability of diagnostic options. Recent advances in proteomics are discussed in detail, elucidating the link with nsLTP-related allergies. The proteomics advancements have paved the way for more reliable diagnostics, especially component-based tools. Finally, the current experience in treatment options is highlighted. Expert opinion: Cannabis allergy is an allergy entity which can significantly impact the quality of life. For optimal diagnosis, we advise to start with a validated and standardized crude-extract based test such as sIgE hemp complemented by component-based diagnostics such as sIgE Can s 3 quantifications where available. Future research should lift the veil on the true prevalence of cannabis allergy and the importance of other cannabis allergens to further guide our practice.

摘要

尽管大麻的使用可以追溯到几千年前,但大麻过敏的第一个描述相对较新(1971 年)。最近的大规模数据表明,大麻过敏会表现出严重和广泛的症状,并伴有广泛的交叉反应。因此,熟悉其临床表现、诊断辅助手段和适当的治疗指导至关重要。涵盖领域:在这里,我们提供了一个关于大麻过敏的实用概述,重点介绍了症状和诊断选择的可靠性。详细讨论了蛋白质组学的最新进展,阐明了其与 nsLTP 相关过敏的联系。蛋白质组学的进步为更可靠的诊断铺平了道路,特别是基于成分的工具。最后,突出了当前治疗选择的经验。专家意见:大麻过敏是一种会显著影响生活质量的过敏实体。为了获得最佳诊断,我们建议首先使用基于经过验证和标准化的粗提取物的测试,例如 hemp sIgE,同时结合基于成分的诊断,例如在有条件的情况下进行 Can s 3 定量 sIgE。未来的研究应该揭示大麻过敏的真实流行率以及其他大麻过敏原的重要性,以进一步指导我们的实践。

相似文献

1
Cannabis allergy: what the clinician needs to know in 2019.2019 年临床医生需要了解的大麻过敏知识。
Expert Rev Clin Immunol. 2019 Jun;15(6):599-606. doi: 10.1080/1744666X.2019.1600403. Epub 2019 Apr 4.
2
Exploring the Diagnosis and Profile of Cannabis Allergy.探讨大麻过敏的诊断和特征。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):983-989.e5. doi: 10.1016/j.jaip.2018.09.017. Epub 2018 Sep 29.
3
Cannabis Allergy: What do We Know Anno 2015.大麻过敏:2015年我们了解了什么。
Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):327-32. doi: 10.1007/s00005-015-0352-z. Epub 2015 Jul 16.
4
Cannabis sativa allergy: looking through the fog.大麻过敏:拨云见日。
Allergy. 2017 Feb;72(2):201-206. doi: 10.1111/all.13043. Epub 2016 Sep 27.
5
The Diagnosis of Allergy to Lipid Transfer Proteins.脂质转运蛋白过敏的诊断。
Curr Allergy Asthma Rep. 2024 Sep;24(9):509-518. doi: 10.1007/s11882-024-01164-8. Epub 2024 Jul 11.
6
Cannabis allergy: A diagnostic challenge.大麻过敏:一项诊断挑战。
Allergy. 2018 Sep;73(9):1911-1914. doi: 10.1111/all.13491. Epub 2018 Jun 17.
7
Prevalence of sensitization to Cannabis sativa. Lipid-transfer and thaumatin-like proteins are relevant allergens.大麻致敏的流行情况。脂转移蛋白和天花粉样蛋白是相关过敏原。
Int Arch Allergy Immunol. 2013;162(2):115-22. doi: 10.1159/000351068. Epub 2013 Jul 31.
8
Occupational cannabis exposure and allergy risks.职业性大麻暴露与过敏风险。
Occup Environ Med. 2019 Feb;76(2):78-82. doi: 10.1136/oemed-2018-105302. Epub 2018 Dec 15.
9
Cannabis-related allergies: An international overview and consensus recommendations.大麻相关过敏:国际概述和共识建议。
Allergy. 2022 Jul;77(7):2038-2052. doi: 10.1111/all.15237. Epub 2022 Feb 14.
10
Establishing diagnostic strategies for cannabis allergy.建立大麻过敏的诊断策略。
Expert Rev Clin Immunol. 2022 Oct;18(10):1015-1022. doi: 10.1080/1744666X.2022.2108791. Epub 2022 Aug 2.

引用本文的文献

1
The Diagnosis of Allergy to Lipid Transfer Proteins.脂质转运蛋白过敏的诊断。
Curr Allergy Asthma Rep. 2024 Sep;24(9):509-518. doi: 10.1007/s11882-024-01164-8. Epub 2024 Jul 11.
2
Factors and co-factors influencing clinical manifestations in nsLTPs allergy: between the good and the bad.影响非特异性脂质转运蛋白过敏临床表现的因素及辅助因素:介于有益与有害之间。
Front Allergy. 2023 Sep 28;4:1253304. doi: 10.3389/falgy.2023.1253304. eCollection 2023.
3
The Emerging Spectrum of Respiratory Diseases in the U.S. Cannabis Industry.美国大麻产业中新兴的呼吸道疾病谱。
Semin Respir Crit Care Med. 2023 Jun;44(3):405-414. doi: 10.1055/s-0043-1766116. Epub 2023 Apr 4.
4
A review of cannabis allergy in the early days of legalization.合法化早期的大麻过敏综述。
Ann Allergy Asthma Immunol. 2023 Mar;130(3):288-295. doi: 10.1016/j.anai.2022.10.016. Epub 2022 Oct 27.
5
Cannabis-related allergies: An international overview and consensus recommendations.大麻相关过敏:国际概述和共识建议。
Allergy. 2022 Jul;77(7):2038-2052. doi: 10.1111/all.15237. Epub 2022 Feb 14.
6
Epitope Mapping of Allergenic Lipid Transfer Proteins.过敏原脂质转移蛋白的表位作图。
Methods Mol Biol. 2021;2344:107-117. doi: 10.1007/978-1-0716-1562-1_8.
7
Non-specific lipid-transfer proteins: Allergen structure and function, cross-reactivity, sensitization, and epidemiology.非特异性脂质转运蛋白:变应原的结构与功能、交叉反应性、致敏作用及流行病学
Clin Transl Allergy. 2021 May 18;11(3):e12010. doi: 10.1002/clt2.12010. eCollection 2021 May.
8
Occupational Allergies to Cannabis.职业性大麻过敏
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3331-3338. doi: 10.1016/j.jaip.2020.09.003.
9
Allergic and Respiratory Symptoms in Employees of Indoor Cannabis Grow Facilities.室内大麻种植设施员工的过敏和呼吸道症状。
Ann Work Expo Health. 2020 Aug 6;64(7):754-764. doi: 10.1093/annweh/wxaa050.
10
Cannabis: An Emerging Occupational Allergen?大麻:一种新兴的职业过敏原?
Ann Work Expo Health. 2020 Aug 6;64(7):679-682. doi: 10.1093/annweh/wxaa043.